Vitamin D deficiency is an independent risk factor and is predictor of infections in patients affected by HCV-related liver cirrhosis

被引：0
|
作者：
Buonomo, A. R. [1 ]
Zappulo, E. [1 ]
Scotto, R. [1 ]
Pinchera, B. [1 ]
Maraolo, A. E. [1 ]
Borrelli, F. [1 ]
Di Filippo, G. [1 ]
Borgia, G. [1 ]
Gentile, I. [1 ]
机构：
[1] Univ Naples Federico II, Infect Dis Sect, Dept Clin Med & Surg, Naples, Italy
来源：
DIGESTIVE AND LIVER DISEASE | 2017年 / 49卷 / 01期
关键词：
D O I：
10.1016/j.dld.2017.01.067
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
T-29
引用
收藏
页码：E31 / E32
页数：4
相关论文
共 50 条
  • [21] Low Serum 25-Hydroxy Vitamin D (25-OHD) and Hepatic Encephalopathy in HCV-Related Liver Cirrhosis
    Afifi, Mohamed Abd Ellatif
    Hussein, Ahmed Mohamed
    Rizk, Mahmoud
    INTERNATIONAL JOURNAL OF HEPATOLOGY, 2021, 2021
  • [22] Vitamin D Deficiency Is an Independent Risk Factor for Urinary Tract Infections After Renal Transplants
    Kwon, Young Eun
    Kim, Hyunwook
    Oh, Hyung Jung
    Park, Jung Tak
    Han, Seung Hyeok
    Ryu, Dong-Ryeol
    Yoo, Tae-Hyun
    Kong, Shin-Wook
    MEDICINE, 2015, 94 (09) : e594
  • [23] VITAMIN D DEFICIENCY IS AN INDEPENDENT RISK FACTOR FOR URINARY TRACT INFECTIONS AFTER RENAL TRANSPLANTS
    Han, In Mee
    Ryu, Geun Woo
    Jhee, Jong Hyun
    Kim, Hyung Woo
    Lee, Sul A.
    Park, Seo Hyun
    Jung, Su-Young
    Kee, Youn Kyung
    Han, Seung Gyu
    Yoon, Chang-Yun
    Kwon, Young Eun
    Park, Kyung Sook
    Kang, Shin-Wook
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2015, 30
  • [24] Vitamin D deficiency in patients with chronic liver disease and cirrhosis
    Lim L.Y.
    Chalasani N.
    Current Gastroenterology Reports, 2012, 14 (1) : 67 - 73
  • [25] Th2 Dominance Might Induce Carcinogenesis in Patients with HCV-related Liver Cirrhosis
    Kogame, Michio
    Nagai, Hidenari
    Shinohara, Mie
    Igarashi, Yoshinori
    Sumino, Yasukiyo
    Ishii, Koji
    ANTICANCER RESEARCH, 2016, 36 (09) : 4529 - 4536
  • [26] IS VITAMIN D DEFICIENCY AN INDEPENDENT RISK FACTOR FOR PERIPHERAL NEUROPATHY?
    Luo, Jin Jun
    Bumanlag, Favio
    Dun, Nae
    MUSCLE & NERVE, 2019, 60 : S41 - S41
  • [27] Regression of liver stiffness in patients with HCV-related compensated cirrhosis after viral eradication by DAAs
    Vigano, Mauro
    Brancaccio, Giuseppina
    Labanca, Sara
    Cantone, Marco
    Occhipinti, Vincenzo
    Gaeta, Giovanni Battista B.
    Rumi, Maria Grazia
    HEPATOLOGY, 2017, 66 : 836A - 837A
  • [28] The Effect of Splenectomy and Subsequent Interferon Therapy in Patients With HCV-Related Liver Cirrhosis in the Long Term
    Inagaki, Yuji
    Yamamoto, Norihiko
    Shiraki, Katsuya
    Yada, Takazumi
    Yoshizawa, Naohiko
    Beppu, Tetsuya
    Sugimoto, Kazushi
    Ogura, Suguru
    Tameda, Masahiko
    Kusagawa, Satoko
    Nojiri, Keiichiro
    Takei, Yoshiyuki
    Sakurai, Hiroyuki
    Isaji, Shuji
    GASTROENTEROLOGY, 2013, 144 (05) : S984 - S984
  • [29] Circulating microparticles and thrombotic risk in patients with HCV-related cirrhosis who underwent DAA treatment
    Zanetto, A.
    Campello, Elena
    Franceschet, E.
    Shalaby, S.
    Ferrarese, A.
    Sciarrone, S.
    Becchetti, C.
    Gambato, M.
    Germani, G.
    Senzolo, M.
    Simioni, P.
    Burra, P.
    Russo, F. P.
    JOURNAL OF HEPATOLOGY, 2018, 68 : S538 - S539
  • [30] Liver cell proliferation by PCNA and HCV recurrence in patients transplanted for HCV-related cirrhosis with or without hepatocellular carcinoma.
    Donato, MF
    Agnelli, F
    Arosio, E
    Monti, V
    Balestrieri, MR
    Rizzi, P
    Colombo, M
    HEPATOLOGY, 2001, 34 (04) : 408A - 408A
12345